| Entry |
|
|---|
| Name |
Dextroamphetamine sulfate (USP);
Dexedrine (TN);
Dextrostat (TN) |
|---|
| Product |
|
|---|
| Generic |
DEXTROAMPHETAMINE (Tris Pharma), DEXTROAMPHETAMINE SULFATE (Actavis Pharma), DEXTROAMPHETAMINE SULFATE (Amneal Pharmaceuticals of New York LLC), ZENZEDI (Arbor Pharmaceuticals), DEXTROAMPHETAMINE SULFATE (Aurolife Pharma), DEXTROAMPHETAMINE SULFATE (Bryant Ranch Prepack), DEXTROAMPHETAMINE SULFATE (Bryant Ranch Prepack), PROCENTRA (Independence Pharmaceuticals), DEXTROAMPHETAMINE SULFATE (KVK-Tech), DEXTROAMPHETAMINE SULFATE (Lupin Pharmaceuticals), DEXTROAMPHETAMINE SULFATE (Mayne Pharma), DEXTROAMPHETAMINE SULFATE (Prasco Laboratories), DEXTROAMPHETAMINE SULFATE (SUNRISE PHARMACEUTICAL), DEXTROAMPHETAMINE SULFATE (SpecGx LLC), DEXTROAMPHETAMINE SULFATE (SpecGx LLC), DEXTROAMPHETAMINE SULFATE (Teva Pharmaceuticals USA), DEXTROAMPHETAMINE SULFATE (Wilshire Pharmaceuticals), DEXTROAMPHETAMINE SULFATE (Winder Laboratories LLC), DEXTROAMPHETAMINE SULFATE (Zydus Pharmaceuticals (USA)), DEXTROAMPHETAMINE SULFATE (Zydus Pharmaceuticals (USA)) |
|---|
| Formula |
(C9H13N)2. H2SO4
|
|---|
| Exact mass |
368.177
|
|---|
| Mol weight |
368.4909
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG03085 Selective norepinephrine reuptake inhibitor (NRI)
|
|---|
| Remark |
| Product (DG00967): | D02078<US> |
| Product (mixture): | D11624<US> |
|
|---|
| Efficacy |
Stimulant (central) |
|---|
| Disease |
Narcolepsy [DS: H01293] Attention deficit disorder with hyperactivity [DS: H01895] |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07234 | Neurotransmitter transporter inhibitors |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
N06BA Centrally acting sympathomimetics
N06BA02 Dexamfetamine
D02078 Dextroamphetamine sulfate (USP) <US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Attention Deficit Hyperactivity Disorder Agents, Amphetamines
Dextroamphetamine
D02078 Dextroamphetamine sulfate (USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03085 Selective norepinephrine reuptake inhibitor (NRI)
DG00967 Dexamfetamine
D02078 Dextroamphetamine sulfate
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D02078 Dextroamphetamine sulfate (USP) <US>
SLC6A3 (DAT1)
D02078 Dextroamphetamine sulfate (USP) <US>
SLC18
SLC18A2 (VMAT2)
D02078 Dextroamphetamine sulfate (USP) <US>
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03085 Selective norepinephrine reuptake inhibitor (NRI)
DG00967 Dexamfetamine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 25
1 C8y C 24.7800 -14.3500
2 C8x C 23.5900 -13.6500
3 C8x C 24.7800 -15.7500
4 C1b C 25.9700 -13.6500
5 C8x C 22.3300 -14.3500
6 C8x C 23.5900 -16.4500
7 C1c C 27.2300 -14.3500
8 C8x C 22.3300 -15.7500
9 C1a C 28.4200 -13.6500
10 N1a N 27.2300 -15.7500
11 S4a S 33.6700 -14.9100
12 O1d O 33.6700 -13.5100
13 O1d O 33.6700 -16.3100
14 O1d O 35.0700 -14.9100
15 O1d O 32.2700 -14.9100
16 C8y C 24.7800 -14.3500
17 C8x C 23.5900 -13.6500
18 C8x C 22.3300 -14.3500
19 C8x C 22.3300 -15.7500
20 C8x C 23.5900 -16.4500
21 C8x C 24.7800 -15.7500
22 C1b C 25.9700 -13.6500
23 C1c C 27.2300 -14.3500
24 C1a C 28.4200 -13.6500
25 N1a N 27.2300 -15.7500
BOND 24
1 11 12 2
2 11 13 2
3 11 14 1
4 11 15 1
5 1 2 2
6 1 3 1
7 1 4 1
8 2 5 1
9 3 6 2
10 4 7 1
11 5 8 2
12 7 9 1
13 7 10 1 #Down
14 6 8 1
15 16 17 2
16 16 21 1
17 16 22 1
18 17 18 1
19 21 20 2
20 22 23 1
21 18 19 2
22 23 24 1
23 23 25 1 #Down
24 20 19 1
BRACKET 1 21.7000 -17.4300 21.7000 -12.5300
1 29.8900 -12.5300 29.8900 -17.4300
1 2
ORIGINAL 1 1 2 5 8 6 3 4 7 9 10
REPEAT 1 16 17 18 19 20 21 22 23 24 25
|
|---|
